73 related articles for article (PubMed ID: 24648347)
21. SRC-3, a Steroid Receptor Coactivator: Implication in Cancer.
Li L; Deng CX; Chen Q
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946224
[TBL] [Abstract][Full Text] [Related]
22. The function of steroid receptor coactivator-1 in normal tissues and cancer.
Walsh CA; Qin L; Tien JC; Young LS; Xu J
Int J Biol Sci; 2012; 8(4):470-85. PubMed ID: 22419892
[TBL] [Abstract][Full Text] [Related]
23. SRC-1 Regulates Blood Pressure and Aortic Stiffness in Female Mice.
Hinton AO; Yang Y; Quick AP; Xu P; Reddy CL; Yan X; Reynolds CL; Tong Q; Zhu L; Xu J; Wehrens XH; Xu Y; Reddy AK
PLoS One; 2016; 11(12):e0168644. PubMed ID: 28006821
[TBL] [Abstract][Full Text] [Related]
24. Steroid receptor coactivator 1 is an integrator of glucose and NAD+/NADH homeostasis.
Motamed M; Rajapakshe KI; Hartig SM; Coarfa C; Moses RE; Lonard DM; O'Malley BW
Mol Endocrinol; 2014 Mar; 28(3):395-405. PubMed ID: 24438340
[TBL] [Abstract][Full Text] [Related]
25. Hepatic SRC-1 activity orchestrates transcriptional circuitries of amino acid pathways with potential relevance for human metabolic pathogenesis.
Tannour-Louet M; York B; Tang K; Stashi E; Bouguerra H; Zhou S; Yu H; Wong LJ; Stevens RD; Xu J; Newgard CB; O'Malley BW; Louet JF
Mol Endocrinol; 2014 Oct; 28(10):1707-18. PubMed ID: 25148457
[TBL] [Abstract][Full Text] [Related]
26. Nuclear Receptor Coactivator 2 Promotes Human Breast Cancer Cell Growth by Positively Regulating the MAPK/ERK Pathway.
Cai M; Liang X; Sun X; Chen H; Dong Y; Wu L; Gu S; Han S
Front Oncol; 2019; 9():164. PubMed ID: 30941313
[TBL] [Abstract][Full Text] [Related]
27. Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer.
Ali A; Creevey L; Hao Y; McCartan D; O'Gaora P; Hill A; Young L; McIlroy M
Breast Cancer Res; 2015 Sep; 17(1):123. PubMed ID: 26341737
[TBL] [Abstract][Full Text] [Related]
28. E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter.
Chu J; Zhu Y; Liu Y; Sun L; Lv X; Wu Y; Hu P; Su F; Gong C; Song E; Liu B; Liu Q
Oncotarget; 2015 Oct; 6(31):31944-57. PubMed ID: 26397135
[TBL] [Abstract][Full Text] [Related]
29. Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine Therapy.
McBryan J; Fagan A; McCartan D; Bane FT; Varešlija D; Cocchiglia S; Byrne C; Bolger J; McIlroy M; Hudson L; Tibbitts P; Gaora PÓ; Hill AD; Young LS
Clin Cancer Res; 2015 Dec; 21(23):5371-9. PubMed ID: 26240272
[TBL] [Abstract][Full Text] [Related]
30. KDM4C (GASC1) lysine demethylase is associated with mitotic chromatin and regulates chromosome segregation during mitosis.
Kupershmit I; Khoury-Haddad H; Awwad SW; Guttmann-Raviv N; Ayoub N
Nucleic Acids Res; 2014 Jun; 42(10):6168-82. PubMed ID: 24728997
[TBL] [Abstract][Full Text] [Related]
31. Changes in Expression of Genes Representing Key Biologic Processes after Neoadjuvant Chemotherapy in Breast Cancer, and Prognostic Implications in Residual Disease.
Klintman M; Buus R; Cheang MC; Sheri A; Smith IE; Dowsett M
Clin Cancer Res; 2016 May; 22(10):2405-16. PubMed ID: 27179111
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of PAWR by small activating RNAs induces cell apoptosis in human prostate cancer cells.
Yang K; Shen J; Chen SW; Qin J; Zheng XY; Xie LP
Oncol Rep; 2016 Apr; 35(4):2487-93. PubMed ID: 26797252
[TBL] [Abstract][Full Text] [Related]
33. Active Estrogen-Succinate Metabolism Promotes Heme Accumulation and Increases the Proliferative and Invasive Potential of Endometrial Cancer Cells.
Lu JJ; Zhang X; Abudukeyoumu A; Lai ZZ; Hou DY; Wu JN; Tao X; Li MQ; Zhu XY; Xie F
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509133
[TBL] [Abstract][Full Text] [Related]
34. HOXC11 drives lung adenocarcinoma progression through transcriptional regulation of SPHK1.
Peng X; Liu X; Hu W; Zhou Y; Ouyang L; Peng X; Long Y; Sun J; Tao T; Chen L; Shi Y; Tao Y; Xiao D; Liu S
Cell Death Dis; 2023 Feb; 14(2):153. PubMed ID: 36823149
[TBL] [Abstract][Full Text] [Related]
35. Nuclear receptor coactivator SRC-1 promotes colorectal cancer progression through enhancing GLI2-mediated Hedgehog signaling.
Guo P; Chen Q; Peng K; Xie J; Liu J; Ren W; Tong Z; Li M; Xu J; Zhang Y; Yu C; Mo P
Oncogene; 2022 May; 41(20):2846-2859. PubMed ID: 35418691
[TBL] [Abstract][Full Text] [Related]
36. KDM4 Involvement in Breast Cancer and Possible Therapeutic Approaches.
Varghese B; Del Gaudio N; Cobellis G; Altucci L; Nebbioso A
Front Oncol; 2021; 11():750315. PubMed ID: 34778065
[TBL] [Abstract][Full Text] [Related]
37. Development of improved SRC-3 inhibitors as breast cancer therapeutic agents.
Qin L; Chen J; Lu D; Jain P; Yu Y; Cardenas D; Peng X; Yu X; Xu J; Wang J; O'Malley BW; Lonard DM
Endocr Relat Cancer; 2021 Aug; 28(10):657-670. PubMed ID: 34310341
[TBL] [Abstract][Full Text] [Related]
38. The Significance of HOXC11 and LSH in Survival Prediction in Gastric Adenocarcinoma.
Peng X; Sun J; Long Y; Xiao D; Zhou J; Tao Y; Liu S
Onco Targets Ther; 2021; 14():1517-1529. PubMed ID: 33688200
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype.
Varešlija D; Ward E; Purcell SP; Cosgrove NS; Cocchiglia S; O'Halloran PJ; Charmsaz S; Bane FT; Brett FM; Farrell M; Cryan J; Beausang A; Hudson L; Turnbul AK; Dixon JM; Hill ADK; Priedigkeit N; Oesterreich S; Lee AV; Sims AH; Redmond AM; Carroll JS; Young LS
Oncogene; 2021 Feb; 40(7):1318-1331. PubMed ID: 33420368
[TBL] [Abstract][Full Text] [Related]
40. The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy.
Wang J; Xie S; Yang J; Xiong H; Jia Y; Zhou Y; Chen Y; Ying X; Chen C; Ye C; Wang L; Zhou J
J Hematol Oncol; 2019 Jul; 12(1):81. PubMed ID: 31340867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
